Cuba vs Fiji: The number of people with susceptibility test result for rifampicin
Cuba
133
in 2021
Fiji
127
in 2021
Cuba rank
104th
Fiji rank
105th
The number of people with susceptibility test result for rifampicin over time
- Cuba
- Fiji
How they compare
Cuba currently reports 133 against 127 in Fiji, a difference of 6.
Across all 5 years both countries report, Cuba has been ahead every year.
Cuba ranks 104th and Fiji ranks 105th of 155 countries.
Cuba has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cuba | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 316.33 | 139 | 177.33 | Cuba |
| 2020s | 161.5 | 123.5 | 38 | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cuba or Fiji?
- Cuba, at 133 against 127 in Fiji as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cuba and Fiji?
- 6, with Cuba ahead.
- How many years of comparable data are there for Cuba and Fiji?
- 5 years are reported by both, from 2017 to 2021.
- How do Cuba and Fiji rank globally for the number of people with susceptibility test result for rifampicin?
- Cuba ranks 104th and Fiji ranks 105th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.